Logo image of EXPL.PA

EXPLOSIFS PROD. CHI (EXPL.PA) Stock Fundamental Analysis

Europe - EPA:EXPL - FR0014003AQ4 - Common Stock

205 EUR
+2 (+0.99%)
Last: 9/22/2025, 5:20:06 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to EXPL. EXPL was compared to 69 industry peers in the Chemicals industry. EXPL has an excellent profitability rating, but there are some minor concerns on its financial health. EXPL is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

EXPL had positive earnings in the past year.
EXPL had a positive operating cash flow in the past year.
Of the past 5 years EXPL 4 years were profitable.
EXPL had a positive operating cash flow in each of the past 5 years.
EXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFEXPL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M

1.2 Ratios

Looking at the Return On Assets, with a value of 4.98%, EXPL is in the better half of the industry, outperforming 73.91% of the companies in the same industry.
EXPL's Return On Equity of 14.04% is amongst the best of the industry. EXPL outperforms 81.16% of its industry peers.
The Return On Invested Capital of EXPL (6.36%) is better than 66.67% of its industry peers.
EXPL had an Average Return On Invested Capital over the past 3 years of 6.01%. This is in line with the industry average of 6.84%.
The last Return On Invested Capital (6.36%) for EXPL is above the 3 year average (6.01%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROIC 6.36%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
EXPL.PA Yearly ROA, ROE, ROICEXPL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 -20

1.3 Margins

The Profit Margin of EXPL (4.77%) is better than 60.87% of its industry peers.
EXPL's Profit Margin has improved in the last couple of years.
EXPL has a Operating Margin of 4.22%. This is comparable to the rest of the industry: EXPL outperforms 47.83% of its industry peers.
In the last couple of years the Operating Margin of EXPL has grown nicely.
Looking at the Gross Margin, with a value of 60.41%, EXPL belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
EXPL's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
EXPL.PA Yearly Profit, Operating, Gross MarginsEXPL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so EXPL is destroying value.
The number of shares outstanding for EXPL has been increased compared to 1 year ago.
Compared to 5 years ago, EXPL has more shares outstanding
EXPL has a better debt/assets ratio than last year.
EXPL.PA Yearly Shares OutstandingEXPL.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M
EXPL.PA Yearly Total Debt VS Total AssetsEXPL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 2.70 indicates that EXPL is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a decent Altman-Z score value of 2.70, EXPL is doing good in the industry, outperforming 65.22% of the companies in the same industry.
EXPL has a debt to FCF ratio of 2.38. This is a good value and a sign of high solvency as EXPL would need 2.38 years to pay back of all of its debts.
EXPL's Debt to FCF ratio of 2.38 is amongst the best of the industry. EXPL outperforms 91.30% of its industry peers.
EXPL has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
With a Debt to Equity ratio value of 0.40, EXPL perfoms like the industry average, outperforming 57.97% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Altman-Z 2.7
ROIC/WACC0.85
WACC7.53%
EXPL.PA Yearly LT Debt VS Equity VS FCFEXPL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M

2.3 Liquidity

EXPL has a Current Ratio of 1.26. This is a normal value and indicates that EXPL is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of EXPL (1.26) is worse than 78.26% of its industry peers.
A Quick Ratio of 0.94 indicates that EXPL may have some problems paying its short term obligations.
EXPL has a Quick ratio (0.94) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 0.94
EXPL.PA Yearly Current Assets VS Current LiabilitesEXPL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

5

3. Growth

3.1 Past

EXPL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 8.64%, which is quite good.
The Earnings Per Share has been growing by 51.47% on average over the past years. This is a very strong growth
The Revenue has been growing slightly by 1.64% in the past year.
The Revenue has been growing slightly by 7.27% on average over the past years.
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%

3.2 Future

The Earnings Per Share is expected to grow by 17.28% on average over the next years. This is quite good.
The Revenue is expected to grow by 3.63% on average over the next years.
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A

3.3 Evolution

Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
EXPL.PA Yearly Revenue VS EstimatesEXPL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
EXPL.PA Yearly EPS VS EstimatesEXPL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2024 2025 2026 2027 5 10 15

6

4. Valuation

4.1 Price/Earnings Ratio

EXPL is valuated rather expensively with a Price/Earnings ratio of 18.57.
Compared to the rest of the industry, the Price/Earnings ratio of EXPL indicates a somewhat cheap valuation: EXPL is cheaper than 68.12% of the companies listed in the same industry.
EXPL is valuated rather cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 14.01, EXPL is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of EXPL indicates a somewhat cheap valuation: EXPL is cheaper than 72.46% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.86. EXPL is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 18.57
Fwd PE 14.01
EXPL.PA Price Earnings VS Forward Price EarningsEXPL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of EXPL is on the same level as its industry peers.
Based on the Price/Free Cash Flow ratio, EXPL is valued cheaper than 88.41% of the companies in the same industry.
Industry RankSector Rank
P/FCF 11.41
EV/EBITDA 11.08
EXPL.PA Per share dataEXPL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200

4.3 Compensation for Growth

EXPL's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EXPL has an outstanding profitability rating, which may justify a higher PE ratio.
EXPL's earnings are expected to grow with 17.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.96
PEG (5Y)N/A
EPS Next 2Y21.01%
EPS Next 3Y17.28%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.75%, EXPL is not a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.11, EXPL is paying slightly less dividend.
Compared to an average S&P500 Dividend Yield of 2.38, EXPL's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.75%

5.2 History

The dividend of EXPL decreases each year by -6.39%.
Dividend Growth(5Y)-6.39%
Div Incr Years1
Div Non Decr Years1
EXPL.PA Yearly Dividends per shareEXPL.PA Yearly Dividends per shareYearly Dividends per share 2019 2024 2025 0.5 1

5.3 Sustainability

9.03% of the earnings are spent on dividend by EXPL. This is a low number and sustainable payout ratio.
DP9.03%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EXPL.PA Yearly Income VS Free CF VS DividendEXPL.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M 30M 40M
EXPL.PA Dividend Payout.EXPL.PA Dividend Payout, showing the Payout Ratio.EXPL.PA Dividend Payout.PayoutRetained Earnings

EXPLOSIFS PROD. CHI

EPA:EXPL (9/22/2025, 5:20:06 PM)

205

+2 (+0.99%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.7%
Inst Owner ChangeN/A
Ins Owners10.85%
Ins Owner ChangeN/A
Market Cap463.30M
Analysts42.22
Price Target221.34 (7.97%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.75%
Yearly Dividend1
Dividend Growth(5Y)-6.39%
DP9.03%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 18.57
Fwd PE 14.01
P/S 0.95
P/FCF 11.41
P/OCF 6.91
P/B 2.78
P/tB 3.09
EV/EBITDA 11.08
EPS(TTM)11.04
EY5.39%
EPS(NY)14.64
Fwd EY7.14%
FCF(TTM)17.96
FCFY8.76%
OCF(TTM)29.69
OCFY14.48%
SpS216.88
BVpS73.67
TBVpS66.32
PEG (NY)0.96
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 4.98%
ROE 14.04%
ROCE 7.48%
ROIC 6.36%
ROICexc 6.41%
ROICexgc 6.82%
OM 4.22%
PM (TTM) 4.77%
GM 60.41%
FCFM 8.28%
ROA(3y)4.63%
ROA(5y)2%
ROE(3y)14.6%
ROE(5y)5.29%
ROIC(3y)6.01%
ROIC(5y)4.98%
ROICexc(3y)6.49%
ROICexc(5y)5.43%
ROICexgc(3y)6.91%
ROICexgc(5y)5.79%
ROCE(3y)7.04%
ROCE(5y)5.85%
ROICexcg growth 3Y2.1%
ROICexcg growth 5Y14.44%
ROICexc growth 3Y2.48%
ROICexc growth 5Y15.88%
OM growth 3Y7.17%
OM growth 5Y14.75%
PM growth 3Y45.4%
PM growth 5YN/A
GM growth 3Y0.5%
GM growth 5Y11.18%
F-Score6
Asset Turnover1.04
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 2.38
Debt/EBITDA 1.33
Cap/Depr 91.37%
Cap/Sales 5.41%
Interest Coverage 3.37
Cash Conversion 135.01%
Profit Quality 173.71%
Current Ratio 1.26
Quick Ratio 0.94
Altman-Z 2.7
F-Score6
WACC7.53%
ROIC/WACC0.85
Cap/Depr(3y)105.91%
Cap/Depr(5y)86.48%
Cap/Sales(3y)5.43%
Cap/Sales(5y)5.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)8.64%
EPS 3Y51.47%
EPS 5YN/A
EPS Q2Q%21.81%
EPS Next Y19.38%
EPS Next 2Y21.01%
EPS Next 3Y17.28%
EPS Next 5YN/A
Revenue 1Y (TTM)1.64%
Revenue growth 3Y9.08%
Revenue growth 5Y7.27%
Sales Q2Q%3.44%
Revenue Next Year3.21%
Revenue Next 2Y4.19%
Revenue Next 3Y3.63%
Revenue Next 5YN/A
EBIT growth 1Y22.43%
EBIT growth 3Y16.9%
EBIT growth 5Y23.09%
EBIT Next Year87.74%
EBIT Next 3Y32.42%
EBIT Next 5YN/A
FCF growth 1Y284.59%
FCF growth 3Y49.53%
FCF growth 5Y77.86%
OCF growth 1Y102.52%
OCF growth 3Y33.74%
OCF growth 5Y25.45%